Analysis··3 min read
S&P 500 at 7,554 — Is the Record Broad Enough to Trust?
The S&P 500 hit a record 7,554, up 1.65% on June 15. Ruslan Averin's read: the index number is clean, but the gap between the Dow, S&P and Nasdaq is the real story.
Analysis
Analysis
Deep dives into markets, strategies, and investment theses.
92 entries
Analysis··3 min readThe U.S.–Iran Deal and the Market's Fastest Risk Repricing of 2026
Ruslan Averin’s read — Trump's U.S.–Iran framework reopened the Strait of Hormuz and reset the geopolitical risk premium overnight. My take: this is what the market repricing a tail risk looks like in real time.
Analysis··3 min readJune 16 Is the Real Test — Why the Fed Matters More Than the Peace Deal
The market rallied on Iran, but the FOMC meets June 16–17 with inflation still sticky at 3.8%. Ruslan Averin's read: the peace deal lit the match, but the Fed decides if the rally burns.
Analysis··3 min readWeek Ahead: Can a Record Built on One Headline Actually Hold?
Three indexes at records, gold and silver at records, oil at two-month lows — all on one weekend. Ruslan Averin's read: the setup is real, but headline-driven records need a second catalyst to survive.
Analysis··3 min readChips Are Up 65% This Year and Nobody's Blinking — I'm Watching the One Crack
The PHLX Semiconductor Index is up over 65% YTD into mid-June 2026, with NVIDIA still leading the AI-capex trade. Ruslan Averin explains why the leg is real, where the 1999 comparison fits, and how he's sizing it.
Analysis··3 min readBaidu Jumped 15% on an AI-Chip Spinoff — and the Chinese ADR Trade Just Got Interesting Again
BIDU broke out roughly 15% on news of an AI-chip division spinoff, even with a Pentagon-list overhang. Ruslan Averin weighs the bull catalyst against the geopolitical tax on every Chinese ADR.
Analysis··3 min readAlphabet Is Quietly Being Re-Rated — and the Apple Gemini Deal Is Why I'm Paying Attention
Into the June 15 risk-on tape, Alphabet is benefiting from a structural re-rating around its TPU stack and a deal to power Apple's Siri overhaul with Gemini. Ruslan Averin breaks down why this mega-cap looks different in 2026.
Analysis··3 min readSpaceX's IPO Didn't Lift the Whole Sector — It Siphoned It. Here's Where the Money Actually Went
SpaceX's historic debut triggered a 'capital siphon' across space stocks — yet KeyBanc upgraded Rocket Lab to overweight in the selloff. Ruslan Averin sorts the halo from the hype across RKLB, RDW and ASTS.
Analysis··3 min readA Peace Deal Should Sink Gold. It Hit a Record Instead. Here's the Real Reason
Conventional wisdom says safe havens fall when peace breaks out. On June 15 gold and silver did the opposite. Ruslan Averin explains the rate, dollar and central-bank mechanics behind the contradiction.
Analysis··3 min readDefense Stocks Fell on the Iran Deal While the S&P Ripped — That's the Trade
Lockheed, Northrop and L3Harris slid 1.1–1.9% as a U.S.–Iran ceasefire lifted the S&P 1.5%. Ruslan Averin on why peace is bad for defense names — and where the durable demand actually sits.
Analysis··3 min readA Record Gold Print on Peace Day Just Told You How Everyone Is Positioned
When safe havens rally into a peace deal, the tape is leaking information about positioning. Ruslan Averin on what gold's record $4,357 print signals about crowding, conviction and the next rotation.
Analysis··3 min readBeijing Just Extended EV Subsidies Into 2026 — NIO and XPeng Popped, and I Think the Trade Has Legs
China confirmed its EV trade-in subsidies run through 2026, and NIO and XPeng jumped ~6%. Analyst Ruslan Averin explains why the policy floor matters more than any single delivery number.
Analysis··3 min readOil Cracked and Money Rotated — Why Airlines and Cyclicals Were the Quiet Winners on June 15
The peace deal sank crude and flipped the sector tape: energy down, airlines and cyclicals up. Analyst Ruslan Averin maps the rotation and where the rate-of-change actually favors you.
Analysis··3 min readIntel (INTC) Is Up 450% in 2026 — And a Google Foundry Order Just Reset the Story Again
Intel rose 6.5% on June 12, extending a 450% 2026 run after Google routed a 3M-chip TPU order to Intel Foundry over TSMC, with BofA upgrading to Buy at $135.
Analysis··3 min readAMD (AMD) Is Up 130% in 2026 — Friday's Pop Was Geopolitics, the Real Story Is the Data Center
AMD rose 4.7% on June 12 as semis rallied on a Trump-Iran breakthrough — but the durable story is a data-center segment up 57% YoY and a BofA target of $560.
Analysis··3 min readMicron (MU) Just Joined the $1 Trillion Club — And UBS Says It Can Still Double
Micron crossed a $1 trillion market cap on June 11 after an 860% run in 12 months — and UBS tripled its price target to $1,625, implying another 115% upside. Here is how I read a memory maker worth a trillion dollars.
Analysis··3 min readQualcomm (QCOM) Jumped on a ByteDance Deal Nobody Saw Coming — Millions of AI Chips
ByteDance is buying millions of Qualcomm AI chips for its data centers — one of Qualcomm's first major ASIC wins in AI infrastructure. The phone-chip company just bought itself a second story.
Analysis··3 min readQuantinuum's $12.7B IPO Is the Stress Test the Quantum Rally Didn't Ask For
Honeywell-backed Quantinuum is going public at up to $12.7B — on $5.2M quarterly revenue and a $136.6M loss. With IONQ +132% since March, this IPO will price the sector's reality.
Analysis··3 min readCerebras (CBRS) at 88x Sales: Wall Street Sees $294 — Here's What the Bulls Are Buying
A month after its IPO, Cerebras trades near $241 with 10 buy ratings, a $294 average target and a $10B OpenAI deal — at 88x sales. The wafer-scale bet against Nvidia, priced for belief.
Analysis··3 min readDell (DELL) Sold $16.1 Billion of AI Servers in One Quarter — And Raised the Bar to $167B
Dell's AI server sales hit $16.1B of a $43.8B quarter — up 88% YoY — and management guided 2027 revenue to $167B against Wall Street's $142B. The boring PC maker is now an AI infrastructure story.
Analysis··3 min readOracle (ORCL) Just Got a Buy Upgrade After a 2% Dip — Here's the Quiet Signal Behind It
Zacks upgraded Oracle to Buy at $201.26 on rising earnings estimates — $7.46 EPS expected for fiscal 2026 and estimates up 1.6% in three months. The signal is the direction, not the headline.
Analysis··3 min readAmerican Airlines (AAL) Jumped 6% on Starlink Wi-Fi for 500+ Jets — Days Before the SpaceX IPO
American Airlines is equipping 500+ jets with Starlink at up to 1 Gbps per aircraft — joining United and Hawaiian while Delta bets on Amazon. AAL jumped 6%, and the timing next to the SpaceX IPO is no accident.
Analysis··3 min readSalesforce (CRM) Is Down 32% This Year — And One Number Decides What Happens Next
Salesforce trades down 31.9% YTD into earnings with Agentforce ARR at $800M growing 169%. The whole AI-software debate now runs through one line of CRM's report.
Analysis··3 min readDollar General (DG) Fell 30% While Its Richest Customers Walked In — The Setup Few See
Dollar General is down 30% since February to under $109 — yet sales are growing, margins improved 60bp, and its fastest-growing customers earn $100k+. The analyst target says $130.
Analysis··3 min readOneok (OKE) Is Up 18% and Still Pays 4.8% — The Catch Is in One Ratio
Oneok rallied 18% in 2026, yields 4.8% ($4.28/share), and 90% of earnings are fee-based across 60,000 miles of pipe. Net income +12%, EBITDA +13%, guidance raised — but the PEG above 2 says the easy money is gone.
Analysis··3 min readArgan (AGX) Doubled Its Backlog to $2.9B — The Power Shortage Is Its Business Model
Argan is up ~90% YTD and 1,000% in five years: Q1 revenue +50% to $291M, EPS nearly doubled, backlog up from $1.4B to $2.9B, zero debt. America is short power plants — Argan builds them.
Analysis··3 min readWingstop (WING) Is Down 39% in Six Months — But Its Margins Say the Market Is Wrong
Wingstop fell 38.7% in six months to $144 — yet runs 25.9% operating margins, 16.3% FCF margins and 4.8% same-store growth. A franchise machine at 30x forward earnings for the first time in years.
Analysis··3 min readNuvalent (NUVL) Jumped ~38% — GSK Is Buying It for $10.6B at $124 a Share
Nuvalent surged ~38% on June 9 after GSK agreed to buy the cancer-drug maker for $10.6B, or $124 a share in cash — a ~40% premium. Here is how I read the deal.
Analysis··3 min readSmucker (SJM) Jumped ~11% on a Q4 Beat — But the Real Story Is the $9+ FY27 Guide
J.M. Smucker beat Q4 FY26 with $2.77 adjusted EPS and jumped ~11% — but the FY27 guide to $9.02–$9.93 and the Uncrustables-and-coffee engine are what changed the thesis.
Analysis··3 min readDraftKings (DKNG) Jumped ~10% as Its Prediction-Market Exchange Goes Live
DKNG rose ~10% as its CFTC-regulated DraftKings Exchange market-maker program went live. The prediction-market push could re-rate the stock beyond state-by-state sportsbook math.
Analysis··3 min readCredo (CRDO) Is Tripling Revenue on AI Connectivity — And Guiding to >80% Growth Again
Credo extended its rally as the chip complex rebounded. Its June 1 beat-and-raise showed FY26 revenue up 3x to $1.34B and a FY27 guide above 80% growth — here is what I watch.
Analysis··3 min readFluence (FLNC) Is Becoming the Battery Layer for AI Data Centers
Fluence extended its surge after Siemens named its SmartStack the only battery-storage partner across seven NVIDIA-ecosystem data-center designs. Here is how I read the AI-grid story.
Analysis··3 min readAxcelis (ACLS) Rode the Semicap Rebound Into a Transformational Veeco Merger
ACLS rose ~10% as chip-equipment names rebounded. The bigger story is the pending Veeco merger that reshapes Axcelis into a larger semicap platform — here is how I read it.
Analysis··3 min readSharkNinja (SN) Keeps Gaining Share — And Raised Its Full-Year Guidance
SN rose with consumer-discretionary names as tariff fears eased. Behind the move: a Q1 beat, raised FY26 guidance, and a relentless product cadence. Here is my read.
Analysis··3 min readWayfair (W) Is Gaining Share in a Brutal Category — And Rate-Cut Hopes Are Helping
W rose with the home-and-retail group on easing-rate hopes. Behind it: market-share gains, a first large-format store, and a loyalty push. Here is how I read the move.
Analysis··3 min readFloor & Decor (FND) Is Rising on Rate-Cut Hopes — Even After a Guidance Cut
FND rose ~7% with housing names on easing-rate hopes — notably, after a Q1 miss and guidance cut. Here is why the macro bid is outrunning the fundamentals for now.
Analysis··3 min readAlignment Healthcare (ALHC) Is Growing ~46% While Medicare Advantage Peers Struggle
ALHC rose ~10% into a healthcare conference. Behind it: 46% revenue growth and 100% of members in 4-Star+ Medicare Advantage plans while rivals fight cost pressure. My read.
Analysis··3 min readHurco Orders Just Jumped 41% to $61.6M — The Demand Signal Behind HURC
Hurco orders surged 41% to $61.6M in fiscal Q2 2026 — and because orders lead sales, that demand signal tells you more about the turnaround than the still-red bottom line.
Analysis··3 min readCooper Companies Crushed Q2 With EPS Up 26% — And the Stock Jumped 8.47%
Cooper Companies posted record fiscal Q2 2026 non-GAAP EPS of $1.21, up 26% and past the $1.10 consensus — its tenth straight beat — and the GAAP loss hiding it is the opportunity. The stock jumped 8.47%.
Analysis··3 min readConcrete Pumping Holdings Beat EPS By 300% And RAISED Guidance — The $26.4M Signal Behind It
Concrete Pumping Holdings posted EPS of $0.04 versus a $0.01 estimate — a 300% beat — and raised full-year guidance. The number that matters: income from operations up 46% on revenue up just 14%.
Analysis··3 min readABM Industries Stock Jumps +6.38% After a Clean Q2 2026 Beat — The Raise Is the Real Story
ABM Industries popped +6.38% on $2.29B revenue and $0.90 adjusted EPS for fiscal Q2 2026 — a clean double beat — but the part that moved the stock was the raised full-year guidance to $3.85-$4.15.
Analysis··3 min readArcBest Is Up 120% in a Year and Just Launched a New Weapon — Here's Why I'm Watching ARCB
ArcBest has returned +120.32% in a year — and just bolted a digital platform onto asset-based revenue growing +10% per day this quarter. Here's why the volume, not the price, is the real story.
Analysis··3 min readCardinal Health Just Raised Guidance to $10+ EPS — And I'm Watching the Actinium-225 Kicker
Cardinal Health raised its fiscal 2026 EPS outlook above $10 while last quarter's adjusted EPS jumped 35% YoY — and the radiopharma kicker is what could re-rate this defensive name.
Analysis··3 min readCencora Just Raised EPS Guidance to $17.90 and Hired a Brand-Name CFO — Here's Why I'm Watching COR
Cencora raised fiscal 2026 adjusted EPS guidance to $17.65-$17.90 on $78.4B in Q2 revenue, then hired a brand-name CFO — three quiet catalysts that tell you this defensive compounder is playing offense.
Analysis··3 min readRepublic Services Beat: I See 16.2% Upside As Net Income Jumps To $525M
Republic Services posted $525M in Q1 net income ($1.70/share, up ~6%) with margins expanding ~50 bps — and the consensus target implies ~16.2% upside while the market looks elsewhere.
Analysis··7 min readBroadcom's AI Chip Warning Repriced the Whole Trade: One Company, One Cautious Outlook, a 4% Nasdaq Day
Broadcom reported this week and a weaker-than-expected AI chip outlook sent its shares plunging — and dragged the Nasdaq down ~4% in a single session. I break down why a company-specific miss became a thesis-level repricing of the entire AI trade.
Analysis··8 min readRuslan Averin: Alphabet +34% Since April — The AI Stack Thesis Playing Out
Alphabet has surged +34% since April, the strongest move since 2004. Q1 EPS $2.81 vs $2.30 estimate. I added at $168 and explain why the AI stack thesis is now confirmed.
Analysis··8 min readRuslan Averin: S&P 500 at 20.9x P/E — The Valuation Wall Institutions Are Pricing
S&P 500 forward P/E at 20.9x — above the 5-year average of 19.2x. I break down what institutions are actually pricing, where margin risk hides, and my hedged position.
Analysis··8 min readRuslan Averin: Warsh Takes the Fed — Rate Hike Odds Jump to 50% in One Week
Kevin Warsh replaces Powell as Fed Chair. Rate hike probability jumped from <1% to 50% in seven days. Here's what that repricing means for bonds, equities, and your portfolio.
Analysis··7 min readRuslan Averin: What the Trump-Xi Summit Means for Asia-Pacific Portfolio Exposure
Trump is planning a visit to Xi Jinping in China to discuss tariffs and AI. My analysis of what a Trump-Xi deal means for Asia-Pacific portfolio exposure, China EM re-rating, and Taiwan strait risk.
Analysis··7 min readThis $4 Billion Pesticide Giant Lost 73% and Just Put Itself Up for Sale — Bargain or Trap?
FMC Corporation is down 73% from its peak and formally on the auction block. Our analysts break down the bull and bear case on the most controversial value stock of 2026.
Analysis··8 min readAlphabet Stock Analysis 2026: AI Stack Thesis and $4.8T Valuation
Alphabet stock analysis 2026: $109.9B Q1 revenue, 81% profit surge, Cloud $20B. Why GOOGL at 28x forward P/E may still make sense.
Analysis··8 min readCopper at $6.41/lb: Why AI Data Centers Are Igniting a Supply Supercycle
Copper is up 37% YoY at $6.41/lb. AI data centers need 27–33 tonnes per MW. Here's the demand math — and the mine supply reality.
Analysis··9 minCorporate Bond Market 2026: IG at 5.3%, HY at 7.8% — Which Tier Is Right for You?
Corporate bond market 2026: IG yields at 5.2–5.4%, HY at 7.5–8%. Record Q1 issuance signals opportunity — and risk. Our analysts assess both tiers.
Analysis··5 minHigh-Yield Bonds in May 2026: The 30-Day Window Our Analysts Are Running
The Fed's rate freeze through June 2026 opens a 30-day window in short-duration high-yield bonds. Our analysts map three positions yielding 6.7–7.9%.
Analysis··7 minQ2 2026 Bond Strategy: Three Positions to Build Before the July FOMC
Q2 2026 is the first full tariff quarter. IG spreads are historically tight, HY has already repriced. Here is where we see value — and what to hedge.
Analysis··8 minThe Full-Year Bond Playbook: How to Position Across 12 Months of Fed Cuts, Tariff Risk, and a Turning Credit Cycle
The Fed is cutting. Here is the complete 2026 bond market playbook — IG ladder construction, high-yield selection, EM opportunity, hedging framework, and three.
Analysis··7 min readBNTX Stock Analysis 2026: mRNA Oncology vs COVID Valuation
BNTX stock broke above 200-day MA. With 47 oncology programs and $10B cash, the market still prices it as a COVID play — that gap is the trade.
Analysis··10 minMitsubishi Corporation (8058): ¥1.17 Trillion Profit, 9% Buffett Stake, and the Largest Buyback — The Flagship Sogo Shosha in 2026
Mitsubishi (8058): $7.8B profit, ¥300B buyback, Buffett at 9% — and trading at 10x earnings. Why this is the strongest risk-adjusted entry in Japanese equities.
Analysis··10 minMitsui & Co. (8031): Record ¥1 Trillion Profit, LNG Backlog, and 9x Earnings — The Commodity Case for 2026
Mitsui cleared ¥1 trillion in net profit for the first time in FY2025 — trading at 9x earnings. The LNG and iron ore thesis, BOJ risks, and the 12-month.
Analysis··10 minItochu Corporation (8001): Buffett's Most Defensive Pick at 12x Earnings — Buy, Hold, or Sell in 2026?
Of Berkshire's five Japanese holdings, Itochu is the most defensive. At ¥7,200 and 12x earnings with 18% ROE, it commands a premium. Here is whether that.
Analysis··9 minSumitomo Corporation (8053): 3.8% Dividend Yield, Copper Upside, and 1.2x Book — The Income and Value Case
Sumitomo offers the highest dividend yield (3.8%) of Japan's Big Five at 1.2x book. The copper thesis, nickel aftermath, and why income investors are watching.
Analysis··9 minMarubeni (8002): The Cheapest Sogo Shosha at Sub-9x Earnings — Maximum Value or Maximum Risk in 2026?
Marubeni (8002) at sub-9x earnings: cheapest of Japan's Big Five with a 3.5% yield. The grain tariff risk is real — but the power infrastructure upside is.
Analysis··7 min readFSLR Stock Forecast 2026: Record Quarter, Target $238
FSLR stock hit record $1B quarterly revenue and broke out 7.1% on earnings. Only US CdTe panel maker — immune to tariffs. Target $238.
Analysis··6 min readUPS Stock 2026: 6% Dividend and 4:1 Institutional Buy Ratio
UPS stock yields 6.1% and institutional buyers ran 4:1 in Q1 2026. Down 45% from peak, the $117–124 buy zone offers asymmetric upside in logistics.
Analysis··8 minReArm Europe: €800B Committed, NATO at 5% GDP — Why Rheinmetall at +3.4% Is a Buying Opportunity
NATO set a 5% GDP defense target. EU committed €800B. Rheinmetall is up just 3.4% YTD while BAE is +23%. Here is why the divergence is a setup.
Analysis··7 min readIBKR Stock Analysis 2026: Buy Zone $118–124, Target $132
IBKR stock consolidates 3% below all-time high. Volatility drives revenue, RSI has room, 14 analysts rate Buy. Entry $118–124, target $132.
Analysis··7 min readUNH Stock 2026: Is the 40% Crash a Buy at $312?
UNH stock crashed 40% then recovered 35%. RSI cooling and CEO transition managed — the $312–340 zone is our structural entry target.
Analysis··6 min readEL Stock Analysis 2026: Estée Lauder at Half Fair Value
EL stock trades at $79 vs GF fair value of $106. Q1 beat sent shares up 11.5% in one session. The bottoming pattern is forming — entry $72–80.
Analysis··8 minGold Down 18% From ATH While Central Banks Buy: What the Broken Correlation Means
Gold fell from $5,589 ATH to ~$4,600. Central banks are still buying. The dollar is at 3-year lows. Why is gold down? The correlation broke.
Analysis··9 min$725 Billion in AI Capex, 90% Zero Productivity Gains: What This Paradox Means for Investors
Hyperscalers commit $725B to AI in 2026. NBER finds 90% of firms report zero productivity gain. Is this the largest misallocation in history — or early cycle?
Analysis··8 minPowell Holds, Warsh Waits — and the Two Men Have Completely Different Theories of Inflation
Powell's last FOMC: 8-4 dissent, core PCE at 3.2%. Kevin Warsh believes tariffs aren't inflationary and AI is deflationary. Here is why that matters.
Analysis··8 minIs the $35 Hormuz Premium Permanent — or One Ceasefire Away From Collapse?
Hormuz closed March 4. Brent hit $126, now $108-116. XLE up 35% YTD. Permian rig count at 4-year lows. Here is what energy markets are actually pricing.
Analysis··7 minBMW Q1 2026: Triple Compression — Tariffs, China Demand, BEV Miss
BMW delivered 565,748 cars in Q1 2026. The stock is down 25% YTD. Three simultaneous pressures explain both numbers.
Analysis··7 minAmerican Airlines Q1 2026 Earnings: $0.53 Beat, Guidance Pulled — The Trade Logic
American Airlines beat Q1 2026 EPS consensus by $0.53 on record loyalty revenue. Management then withdrew annual guidance, citing macro and tariff uncertainty.
Analysis··6 min readSLB Stock 2026: 26 Bullish Signals, Zero Bearish — Target $63
SLB stock flashed 26/26 bullish technical signals and is up 41% YTD. Citi and UBS target $68–69. The cleanest chart in the entire oil sector.
Analysis··6 min readHAL Stock Analysis 2026: Earnings Beat, Resistance Broken, Target $48
HAL stock surged 7% on Q1 beat and broke key resistance the same session. 17 analyst Buy ratings. Entry zone $38–41, target $48.
Analysis··7 min readBKR Stock 2026: Baker Hughes Powers AI Data Centers, Target $80
BKR stock isn't just oilfield — it builds LNG turbines for AI data centers. Susquehanna raised target to $80. Buy zone $62–66.
Analysis··7 min readCAT Stock 2026: +185% Run — Can Caterpillar Hit $1,000?
CAT stock posted a 19% EPS beat and hit all-time highs in Q1 2026. ChartMill 10/10 technical rating. Bull case to $935–1000 backed by AI infrastructure.
Analysis··6 min readEMR Stock Analysis 2026: 1.7GW AI Contract Before Earnings
EMR stock power control orders grew 74% YoY with a 1.7GW AI data center contract. Q2 earnings May 5. Buy zone $138–143.
Analysis··8 minBoeing Q1 2026 Earnings: $0.55 Beat, Cash Burn Turns — Is the Inflection Real?
Boeing Q1 2026 earnings beat consensus by $0.55 on EPS. Cash burn narrowed from -$1.6B to -$179M. The inflection trade is becoming real — with three caveats.
Analysis··8 minULTA Beauty Stock Analysis 2026: After Buffett's Exit, What Now?
Berkshire spent $266M buying ULTA Beauty in 2024, then exited before a 40% rally. Now at $607 with double-digit EPS guidance, is this the setup they abandoned?
- Analysis··8 min
Microsoft Q3 FY2026: Azure Growth Reaccelerates to 35%, Copilot Revenue Finally Visible
Azure accelerates to 35% YoY growth; Copilot seats hit 20M+. Our analysts assess what $80B capex signals for AI dominance.
Analysis··5 minAlphabet Q1 2026 Earnings Analysis: The $2.81 EPS That Rewrote the AI Narrative
Alphabet Q1 2026 earnings analysis: $90.2B revenue, $2.81 EPS vs $2.01 expected, Google Cloud +28% YoY, $70B buyback announced.
Analysis··8 minPfizer (PFE): The Restructuring Nobody Is Watching
Pfizer trades near its lows while quietly rebuilding through oncology, Seagen integration, and a 6.5% yield that keeps the question alive: value trap or.
Analysis··7 minPBF Energy (PBF): Reading the Refiner's Thermometer
PBF Energy is a pure-play independent refiner trading below book, a cyclical thermometer for the American fuel economy that the market prefers to ignore until.
Analysis··8 minPalo Alto Networks (PANW): Platformization and Its Price
PANW is executing a difficult strategic pivot toward full-stack security while trading at 20x revenue. The RPO-to-revenue gap is the single metric that decides.
Analysis··9 minOccidental Petroleum (OXY): Buffett's Hypothesis on American Shale
OXY is a leveraged bet on domestic shale longevity wrapped inside a chemicals-and-midstream chassis. The CrownRock acquisition reshaped the balance sheet. What.
Analysis··8 minRealty Income (O): The Coupon Machine and Its Rate Problem
Thirty years of dividend growth, 15,000+ properties, a 5.7% yield trading at 13x AFFO versus a historical 18–20x. Realty Income is not a growth story — it is a.
Analysis··9 minDubai Real Estate 2025: Cycle Analysis and Entry Timing
Is Dubai property still a buy? I run through supply, demand, and cycle positioning.
Analysis··7 minIron Condor Strategy: How I Generate Monthly Income on SPX
Iron condors on SPX index — my full setup, management rules, and real results.
Analysis··8 minEmerging Markets 2025: Why I'm Increasing Exposure
EM equities are cheap vs. US by almost any metric. Here's my thesis.